CAS 956958-53-5

N-[3-(2,1,3-benzothiadiazol-5-ylamino)quinoxalin-2-yl]-4-methylbenzenesulfonamide

Description:

N-[3-(2,1,3-benzothiadiazol-5-ylamino)quinoxalin-2-yl]-4-methylbenzenesulfonamide is a chemical compound characterized by its complex structure, which includes a sulfonamide group, a quinoxaline moiety, and a benzothiadiazole derivative. This compound is typically recognized for its potential biological activity, particularly in medicinal chemistry, where it may exhibit properties such as antimicrobial or anticancer effects. The presence of the sulfonamide group often contributes to its solubility and reactivity, while the quinoxaline and benzothiadiazole components may enhance its interaction with biological targets. The compound's molecular structure suggests it may participate in various chemical reactions, including nucleophilic substitutions and complexation with metal ions. Its specific applications and efficacy would depend on further empirical studies, including pharmacological evaluations and toxicity assessments. As with many synthetic compounds, understanding its stability, solubility, and reactivity under different conditions is crucial for its potential use in research and therapeutic contexts.

Formula: C₂₁H₁₆N₆O₂S₂

InChI: InChI=1/C21H16N6O2S2/c1-13-6-9-15(10-7-13)31(28,29)27-21-20(23-16-4-2-3-5-17(16)24-21)22-14-8-11-18-19(12-14)26-30-25-18/h2-12H,1H3,(H,22,23)(H,24,27)

SMILES: Cc1ccc(cc1)S(=O)(=O)N=c1c(Nc2ccc3c(c2)nsn3)nc2ccccc2[nH]1

Synonyms:

• SC
• N-[3-(2,1,3-Benzothiadiazol-5-ylamino)-2-quinoxalinyl]-4-methylbenzenesulfonamide
• Pilaralisib
• Xl-147
• 3-Fluoro-5-formylbenzonitrile
• 3-Cyano-5-fluorobenzaldehyde
• N-(3-(benzo[c][1,2,5]thiadiazol-5-ylamino)quinoxalin-2-yl)-4-methylbenzenesulfonamide
• Benzonitrile, 3-fluoro-5-formyl-
• Xl147
• Sar245408
• XL147 analogue(PI3K inhibitor X)
• XL147 USP/EP/BP
• CS-36
• XL147 ANALOG
• PI3K inhibitorX
• N-(3-(Benzo[c][1,2,5]thiadiazol-5-ylamino)quinoxalin-2-yl)-4-methylbenzenes ulfonamide
• XL147;XL-147;SAR245408
• N-[3-(2,1,3-benzothiadiazol-5-ylamino)quinoxalin-2-yl]-4-methylbenzenesulfonamide
• Benzenesulfonamide, N-[3-(2,1,3-benzothiadiazol-5-ylamino)-2-quinoxalinyl]-4-methyl-
• N-[3-(2,1,3-Benzothiadiazol-5-ylamino)-2-quinoxalinyl]-4-methylbenzenesulfonamide XL 147
• XL-147(SAR245408)
• XL147 analogue
• XL147;XL 147
• XL147 ANALOG 1G
• SAR245408 (XL-147)

N-[3-(2,1,3-benzothiadiazol-5-ylamino)quinoxalin-2-yl]-4-methylbenzenesulfonamide

CAS: 956958-53-5

Formula: C₂₁H₁₆N₆O₂S₂

Purity: 98%

Color and Shape: Solid

Molecular weight: 448.5207

Ref: IN-DA00IJCR

N-(3-(Benzo[c][1,2,5]Thiadiazol-5-Ylamino)Quinoxalin-2-Yl)-4-Methylbenzenesulfonamide

CAS: 956958-53-5

N-(3-(Benzo[c][1,2,5]Thiadiazol-5-Ylamino)Quinoxalin-2-Yl)-4-Methylbenzenesulfonamide

Purity: 98+%

Molecular weight: 448.52g/mol

Ref: 54-OR1024392

Pilaralisib analogue

CAS: 956958-53-5

Pilaralisib analogue

Purity: ≥98%

Molecular weight: 448.52g/mol

Ref: 54-BUP09846

Pilaralisib analogue

CAS: 956958-53-5

Pilaralisib analogue (XL147 analogue) is a selective and reversible class I PI3K inhibitor for PI3Kα/δ/γ.

Formula: C₂₁H₁₆N₆O₂S₂

Purity: 99.3% - 99.72%

Color and Shape: Solid

Molecular weight: 448.52

Ref: TM-T2377